Zobrazeno 1 - 5
of 5
pro vyhledávání: '"K. S., Kesavanarayanan"'
Autor:
Unnisa, Aziz, Abouzied Amr S., Anupama B., K. N. V., Chenchu Lakshmi, Kunduru, Ramadevi, K. S., Kesavanarayanan
Publikováno v:
Pharmacophore; Nov/Dec2020, Vol. 11 Issue 6, p74-103, 30p
Publikováno v:
European review for medical and pharmacological sciences. 19(16)
DIA-2 is a herbal mixture containing standardized extract of Allium sativum and Lagerstroemia speciosa. Recently we have reported the anti-diabetic effect of DIA-2 in high fat diet (HFD) and streptozotocin (STZ) induced type 2 diabetic (T2D) rats. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5897500532e8a249eb3eefb3040dcdb3
https://pubmed.ncbi.nlm.nih.gov/26367735
https://pubmed.ncbi.nlm.nih.gov/26367735
Autor:
K S, Kesavanarayanan, S, Sathiya, P, Kalaivani, V, Ranju, A G, Sunil, C, Saravana Babu, S, Kavimani, D, Prathiba
Publikováno v:
European review for medical and pharmacological sciences. 17(3)
The dried bulbs of Allium sativum (Garlic) and leaves of Lagerstroemia speciosa (Banaba) are used as medicinal food for the treatment of diabetes and other ailments.The present study was undertaken to ascertain whether the combination of both garlic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0e1be5cbeefcf262f177e0fdfeafe28f
https://pubmed.ncbi.nlm.nih.gov/23426539
https://pubmed.ncbi.nlm.nih.gov/23426539
Autor:
K S, Kesavanarayanan, S, Sathiya, V, Ranju, A G, Sunil, R, Ilavarasan, C, Saravana Babu, S, Kavimani, D, Prathiba
Publikováno v:
European review for medical and pharmacological sciences. 16
Hyperglycemia induced over production of free radicals in the mitochondrial electron transport chain is now considered as one of the central mechanisms in the pathogenesis of diabetic complications. Allium sativum and Lagerstroemia speciosa contains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5f04538075a07808f9a98708a9e33ce9
https://pubmed.ncbi.nlm.nih.gov/22957419
https://pubmed.ncbi.nlm.nih.gov/22957419
Publikováno v:
Acta Pharmaceutica
Volume 57
Issue 2
Volume 57
Issue 2
Valdecoxib, a selective COX-2 inhibitor, produces serious side effects when given orally. This has led to its withdrawal. Topical application of valdecoxib was formulated and evaluated for its efficacy and safety. Standard procedures were followed an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______951::f870ce32af634ff3a0d39bb42a99b5cf
https://hrcak.srce.hr/file/15165
https://hrcak.srce.hr/file/15165